Clinical Trial Update: Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study [Phase 2]

View source ↗

Summary

The document describes a Phase 2 exploratory study evaluating Adebrelimab plus oral etoposide in elderly or poor performance status patients with Small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Etoposide (oral) (etoposide)

Snippet

Sponsor: The Third Affiliated Hospital of Harbin Medical University | Conditions: Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING